Incannex Healthcare Limited
NASDAQ: IXHL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Joel Bradley Latham
- Employees
- 9
- Headquarters
- Sydney, Australia
- IPO year
- 2022
- Market cap
- $38.9M
- Website
- https://www.incannex.com.au
Loading IXHL…
Loading profile data…Frequently asked questions about IXHL
What does Incannex Healthcare Limited (IXHL) do?
Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid compounds under its proprietary Incannex brand. Its product pipeline includes several key assets: IHL-42X: This compound is currently undergoing Pha...
Where does IXHL trade?
Incannex Healthcare Limited (IXHL) trades on the NASDAQ Global Market.
What sector is IXHL in?
Incannex Healthcare Limited (IXHL) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Incannex Healthcare Limited?
Joel Bradley Latham is the chief executive officer of Incannex Healthcare Limited (IXHL).
Where is Incannex Healthcare Limited headquartered?
Incannex Healthcare Limited is headquartered in Australia.
Does IXHL pay a dividend?
Incannex Healthcare Limited (IXHL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IXHL go public?
Incannex Healthcare Limited (IXHL) completed its initial public offering in 2022.